Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

for
Malignant Mesothelioma, Metastatic Malignant Solid Tumor,
Location: Philadelphia PA, Cleveland OH, Nashville TN, Denver CO,
Sponsor: InSilico Medicine Hong Kong Limited

Sex: All

Age: 18+

Code: NCT06566079

Phase 1, Phase 2, Recruiting

Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer

for
Unspecified Adult Solid Tumor, Protocol Specific
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 18+

Code: NCT00004063

Phase 1, Phase 2, Recruiting

Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Irvine CA, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06910761

Phase 2, Recruiting

A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer

for
Breast Cancer
Location: Montreal, Morgantown WV, Toronto, Germantown TN,
Sponsor: Hoffmann-La Roche

Sex: Female

Age: 18+

Code: NCT07054190

Phase 2, Recruiting

Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors

for
Cancer-related Fatigue, Breast Cancer, Prostate Cancer
Location: Aurora CO, Missoula MT
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 70+

Code: NCT07001241

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

MRg-NIRS Imaging System Breast Cancer Trial

for
Breast Cancer
Location: Lebanon NH
Sponsor: Keith D. Paulsen

Sex: Female

Age: 18 - 70+

Code: NCT06400563

Recruiting

A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies

for
Advanced Solid Tumors
Location: Portland OR
Sponsor: Providence Health & Services

Sex: All

Age: 18+

Code: NCT06719362

Phase 1, Recruiting

Impact of Daily Oral Cannabis Doses in Patients With Cancer

for
Cancer, Cancers, Pain
Location: Lexington KY
Sponsor: Shanna Babalonis, PhD

Sex: All

Age: 18+

Code: NCT06601218

Phase 1, Recruiting

Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Among Cancer Survivors Treated in a Safety Net Hospital

for
Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06760754

Recruiting

Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters

for
Venous Thromboembolism, Cancer
Location: Halifax, Levis, Greenfield Park, Montreal, Ottawa,
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT05029063

Phase 3, Recruiting

A Study of a Distress Screening and Referral Program in People With Recently Diagnosed Cancer

for
Solid Tumor Cancer
Location: Richmond Hill NY, New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07117461

Recruiting

Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers

for
Metastatic Cancer
Location: Chicago IL, Madison WI
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT04295863

Phase 1, Recruiting

Community-Based Physical Activity Intervention for Underserved Cancer Survivors

for
Hematopoietic and Lymphoid System Neoplasm,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT06206863

Recruiting

Breast Cancer Resiliency Through Exercise Program (B-REP)

for
Breast Cancer Female
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: Female

Age: 18+

Code: NCT06100263

Recruiting

Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma

for
Low-grade Glioma, Recurrent Low Grade Glioma,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 2 - 25

Code: NCT07506239

Recruiting

taVNS for Breast Cancer Pain and Symptom Management

for
Breast Cancer Survivors
Location: Tallahassee FL
Sponsor: Florida State University

Sex: Female

Age: 18 - 70+

Code: NCT07500012

Recruiting

Breast Cancer Implementation Science Study With Educational Intervention

for
Breast Cancer
Location: New York NY
Sponsor: NYU Langone Health

Sex: All

Age: 18+

Code: NCT06927895

Recruiting

CBD for Breast Cancer Primary Tumors

for
Breast Cancer
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT06148038

Phase 1, Recruiting

Development of an Educational Patient Decision Aid (Treatments in Advanced Cancer - Decision Aid, TA-DA) to Promote Shared Decision Making for Third-line or Beyond Palliative Systemic Therapy

for
Advanced Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07009886

Recruiting

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

for
Solid Tumor
Location: Fairfax VA, Myrtle Beach SC, Durham NC, Miami FL,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18+

Code: NCT06874335

Phase 1, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial